Literature DB >> 7497890

The effects of lidocaine and bupivacaine on the rabbit retina.

E Zemel1, A Loewenstein, M Lazar, I Perlman.   

Abstract

The toxic action of two commercial anesthetics, lidocaine and bupivacaine, on the functional and morphologic integrity of the retina was investigated in albino and pigmented rabbits. The experimental drug was injected into the vitreous of one eye, while saline solution was injected into the fellow eye. Retinal function was assessed from the electroretinogram and the visual evoked potential. Retinal structure was examined at the light microscopic level. Ten milligrams of lidocaine did not affect the electroretinogram and the visual evoked potential responses, though structural damage could be detected close to the site of injection. A lower dose of 5 mg did not produce any detectable physiologic or morphologic damage. The only dose of bupivacaine used, 0.5 mg, was not toxic to the albino and pigmented rabbit retinas, as assessed by the electroretinogram, visual evoked potential, and light microscopy. The results of this study demonstrate that lidocaine and bupivacaine are nontoxic to the rabbit retina at concentrations that are effective for retrobulbar anesthesia.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7497890     DOI: 10.1007/bf01203338

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  25 in total

1.  Localization of origins of electroretinogram components by intraretinal recording in the intact cat eye.

Authors:  K T BROWN; T N WIESEL
Journal:  J Physiol       Date:  1961-09       Impact factor: 5.182

2.  A new retrobulbar needle and injection technique.

Authors:  J G Straus
Journal:  Ophthalmic Surg       Date:  1988-02

Review 3.  [Eye perforation during retrobulbar anesthesia].

Authors:  J Haut; C Monin; Y Renard; M Tazartes
Journal:  Bull Soc Ophtalmol Fr       Date:  1989 Jun-Jul

4.  Retrobulbar bupivacaine irrigation for postoperative pain after scleral buckling surgery. A prospective study.

Authors:  J S Duker; J Nielsen; J F Vander; R B Rosenstein; W E Benson
Journal:  Ophthalmology       Date:  1991-04       Impact factor: 12.079

5.  Ocular perforation from a retrobulbar injection.

Authors:  M E Schneider; D E Milstein; R T Oyakawa; R R Ober; R Campo
Journal:  Am J Ophthalmol       Date:  1988-07-15       Impact factor: 5.258

6.  Ocular perforation following retrobulbar anesthesia for retinal detachment surgery.

Authors:  R C Ramsay; W H Knobloch
Journal:  Am J Ophthalmol       Date:  1978-07       Impact factor: 5.258

7.  Management of inadvertent intraocular injections.

Authors:  R J Schechter
Journal:  Ann Ophthalmol       Date:  1985-12

8.  The role of ocular pigmentation in protecting against retinal light damage.

Authors:  L M Rapp; T P Williams
Journal:  Vision Res       Date:  1980       Impact factor: 1.886

9.  Drug-induced retinal toxicity in albino rabbits: the effects of imipenem and aztreonam.

Authors:  A Loewenstein; E Zemel; M Lazar; I Perlman
Journal:  Invest Ophthalmol Vis Sci       Date:  1993-11       Impact factor: 4.799

10.  Needle penetration of the globe during retrobulbar and peribulbar injections.

Authors:  A Hay; H W Flynn; J I Hoffman; A H Rivera
Journal:  Ophthalmology       Date:  1991-07       Impact factor: 12.079

View more
  3 in total

Review 1.  Testing retinal toxicity of drugs in animal models using electrophysiological and morphological techniques.

Authors:  Ido Perlman
Journal:  Doc Ophthalmol       Date:  2008-11-09       Impact factor: 2.379

2.  Effects of intravitreal ropivacaine on retinal thickness and integrity in the guinea pig.

Authors:  Gonul Olmez; Sevin Soker Cakmak; Sevda Ipek Soker; Yusuf Nergiz; Fethin Yildiz
Journal:  Curr Ther Res Clin Exp       Date:  2005-07

3.  Effect of Peribulbar Anesthesia with and Without Adrenaline on Retinal Thickness in Patients Undergoing Elective Cataract Surgery.

Authors:  Wael Fathy; Ahmed Taha; Sahar Ibrahim
Journal:  Anesth Pain Med       Date:  2020-04-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.